The Kenya Blood, Cells, Tissues and Organs Bill, 2026

2 Apr 2026 domainNational Assembly No. 18 of 2026 Gazette: Supplement No. 88 of 2026
View original PDF

Status Timeline

Proposed

Active now

Public Review

Pending

Debate

Pending

Executive

Pending

Final

Pending

1

Establishment of the Kenya Blood and Transplant Authority

The Bill establishes a centralized Kenya Blood and Transplant Authority (Clause 6) managed by a Board that includes a chairperson appointed by the President and healthcare professionals. The Authority is tasked with:

  • Coordinating donor recruitment and blood collection.
  • Maintaining a National Waiting List for cells, tissues, and organ recipients.
  • Ensuring the ethical, fair, and equitable allocation of organs.
2

Mandatory Certification for Medical Facilities

To perform transplant-related services, facilities must receive formal certification from the Authority:

  • Transfusing Facilities (Clause 25), Transplant Facilities (Clause 26), and Retrieval Facilities (Clause 27) must apply for and maintain valid certificates.
  • Conducting these operations in an uncertified facility is an offence carrying a fine of up to KSh 500,000, imprisonment for up to two years, or both.
3

Severe Penalties for Commercial Organ Trade

The Bill imposes strict prohibitions on the commercialization of human parts (Clause 103):

  • It bans buying, selling, or offering monetary rewards/compensation for human organs, cells, or tissues.
  • Violating these provisions carries a fine not exceeding KSh 50 million, imprisonment for a term of up to 25 years, or both.
4

Strict Written Consent Rules for Transfusions and Transplants

Informed written consent is legally required before any procedure can occur:

  • Transfusion without consent (Clause 101) is punishable by a fine between KSh 500,000 and KSh 1 million, or up to two years in prison.
  • Transplanting without consent (Clause 102(1)) is punishable by a fine between KSh 5 million and KSh 10 million, or five to ten years in prison.

Comments (0)

No comments yet. Be the first to start the discussion!